William Blair Weighs in on DENTSPLY SIRONA Inc.’s Q2 2018 Earnings (XRAY)
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Investment analysts at William Blair decreased their Q2 2018 earnings estimates for shares of DENTSPLY SIRONA in a report issued on Tuesday. William Blair analyst J. Kreger now forecasts that the medical instruments supplier will earn $0.71 per share for the quarter, down from their prior estimate of $0.72. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 2018 earnings at $0.67 EPS and Q4 2018 earnings at $0.79 EPS.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter last year, the business posted $0.76 EPS. TRADEMARK VIOLATION NOTICE: “William Blair Weighs in on DENTSPLY SIRONA Inc.’s Q2 2018 Earnings (XRAY)” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/05/william-blair-weighs-in-on-dentsply-sirona-inc-s-q2-2018-earnings-xray.html.
Several other equities analysts also recently issued reports on the stock. Cleveland Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Thursday. HC Wainwright restated a “buy” rating and issued a $68.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday. Jefferies Group LLC decreased their price objective on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating for the company in a research note on Wednesday, August 23rd. BidaskClub downgraded shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Finally, Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, August 14th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus price target of $65.67.
Shares of DENTSPLY SIRONA (NASDAQ:XRAY) traded up 1.29% during trading on Thursday, reaching $57.95. The company had a trading volume of 542,244 shares. The firm has a 50-day moving average of $56.90 and a 200 day moving average of $61.30. The firm’s market capitalization is $13.30 billion. DENTSPLY SIRONA has a 1-year low of $52.54 and a 1-year high of $65.68.
Large investors have recently made changes to their positions in the company. Commonwealth Bank of Australia raised its holdings in shares of DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 260 shares during the last quarter. Acrospire Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $113,000. Dupont Capital Management Corp purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $116,000. Korea Investment CORP raised its holdings in shares of DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after buying an additional 1,251 shares during the last quarter. Finally, Sphera Funds Management LTD. purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $162,000. 93.87% of the stock is owned by institutional investors and hedge funds.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.